EUVIMEDAvasta EUVIMED
Open access · CC BY 4.0

Management of Left Atrial Appendage Thrombi and Spontaneous Echo Contrast

Timnou Bekouti Jean iD, Ravakiniaina Ranaivosoa Mialy, Ateba Ateba Nelly Stella, Tsague Kegni Hermann, Rambolarimanana Mansh, Ndobo Julia Valérie, Imbey Eheth Levy, Maury Philippe iD, Diawara Alpha, Roynard Jean Louis, Boombhi Jerome Hilaire

Pacing and Clinical Electrophysiology · 2026-08-19

DOI: 10.1111/pace.70404 ↗

At a glance

Journal article in Pacing and Clinical Electrophysiology, published online on 2026-08-19. Written by Timnou Bekouti Jean and 10 co-authors. Institution: Cardiology Department, Dax-Côte D'argent Hospital Center, Dax, France. 43 references. The full text is freely available (open access, CC BY 4.0).

AbstraktSubjectsBibliograafilised andmedCiteRelated studies

Abstract (original language)

Background

To analyze the efficacy and safety of various anticoagulation strategies/regimen used for managing thrombus or spontaneous echo contrast in the left atrial appendage.

Methods

Thrombus or spontaneous echo contrast in the left atrial appendage was detected via transesophageal echocardiography in 83 patients, most often during a stroke assessment. The chosen anticoagulants were compared, and follow‐up was conducted with repeated transesophageal echocardiograms.

Results

Heparin and vitamin K antagonists (VKAs) were the most commonly selected treatment regimens. The initial resolution rate was approximately 30% across all treatment regimens after a follow‐up of 8 ± 8 weeks (DOACs 30%, VKAs 30%, heparin 25%, p = 0.9). Continuing the same protocol or switching to a direct oral anticoagulant (DOAC) were the main alternatives when the thrombus persisted after the first echocardiographic control. An additional 22% of patients with repeated controls experienced resolution after 23 ± 14 weeks of anticoagulant treatment. Major bleeding events were observed in 3% of patients.

Conclusion

Resolution of thrombi/echo contrasts was noted in a significant proportion of patients with our management approach, without apparent significant differences between treatment regimens (difficult to interpret due to the low number of patients under DOACs). Bleeding complications remain significant.

Subjects

Author keywords

anticoagulantbleedingleft atrial appendagespontaneous contrastthrombus

Authors and institutions

  • Cardiology Department, Dax-Côte D'argent Hospital Center, Dax, France.
  • Interventional Cardiology Center of Douala, Douala, Cameroon.
  • Faculty of Medicine and Biomedical Sciences, Yaoundé, Cameroon.
  • Cardiology Department, Rangueil University Hospital, Toulouse, France.
  • Faculty of Medicine and Pharmaceutical Sciences of Ebolowa, Ebolowa, Cameroon.
  • Neurology Department, Dax-Côte D'argent Hospital Center, Dax, France.

ORCID profiles: Timnou Bekouti Jean, Maury Philippe

Cite

APA

Jean, T. B., Mialy, R. R., Nelly Stella, A. A., Hermann, T. K., Mansh, R., Julia Valérie, N., Levy, I. E., Philippe, M., Alpha, D., Jean Louis, R., & Jerome Hilaire, B. (2026). Management of Left Atrial Appendage Thrombi and Spontaneous Echo Contrast. Pacing and Clinical Electrophysiology. https://doi.org/10.1111/pace.70404

Vancouver

Jean TB, Mialy RR, Nelly Stella AA, Hermann TK, Mansh R, Julia Valérie N, et al. Management of Left Atrial Appendage Thrombi and Spontaneous Echo Contrast. Pacing and Clinical Electrophysiology. 2026. doi:10.1111/pace.70404

BibTeX
@article{Jean2026,
  author = {Jean, Timnou Bekouti and Mialy, Ravakiniaina Ranaivosoa and Nelly Stella, Ateba Ateba and Hermann, Tsague Kegni and Mansh, Rambolarimanana and Julia Valérie, Ndobo and Levy, Imbey Eheth and Philippe, Maury and Alpha, Diawara and Jean Louis, Roynard and Jerome Hilaire, Boombhi},
  title = {Management of Left Atrial Appendage Thrombi and Spontaneous Echo Contrast},
  journal = {Pacing and Clinical Electrophysiology},
  year = {2026},
  doi = {10.1111/pace.70404}
}
Start for free →